Transcripts Abliva AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 17:00:00 27/06/2024 BST			5-day change	1st Jan Change
0.115 ^SEK	-15.19%		-23.33%	-53.16%

05-30	Abliva Concludes Dosing in Mid-stage Study of Mitochondrial Disease Drug	MT
05-30	Abliva AB Announces Completion of 24 Weeks of Dosing in Wave 1 of the Falcon Study of KL1333 in Primary Mitochondrial Disease	CI

Transcript : Abliva AB - Special Call	05-21
Transcript : Abliva AB - Special Call	01/06/22
Transcript : Abliva AB Presents at BioStock Life Science Summit 2020, Nov-17-2020 01:05 PM	17/11/20

No results for this search